abnormal osteoclast differentiation_Fosl2<tm2.1Wag>/Fosl2<tm2.1Wag>

http://metadb.riken.jp/0008396I129P2OlaHsdC57BL6Fosl2tm21WagFosl2tm21WagFosl2tm21Wag

abnormal osteoclast differentiation_Fosl2<tm2.1Wag>/Fosl2<tm2.1Wag>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• fos-like antigen 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:102858

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fosl2<tm2.1Wag>/Fosl2<tm2.1Wag>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Fosl2<tm2.1Wag>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal osteoclast differentiation
  http://purl.obolibrary.org/obo/MP_0008396

文献

http://purl.org/net/cito/citesAsAuthority

• Aline. Bozec, et.al., Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia., Nature, 2008, 454
  http://rdf.ncbi.nlm.nih.gov/pubmed/18548006